TIMMDC1

TIMMDC1 is an inner mitochondrial membrane-embedded assembly factor required for biogenesis of the membrane arm of respiratory chain complex I (PMID:24344204, PMID:24191001). It reciprocally associates with the mitochondrial complex I assembly (MCIA) complex — ACAD9, ECSIT, NDUFAF1 and TMEM126B — and with core complex I subunits, and is found in 550 kDa and 815 kDa membrane-arm assembly intermediates, acting transiently during the build of the Q-, N- and PP-b modules (PMID:24344204, PMID:24191001, PMID:27374774). Loss of TIMMDC1 selectively impairs complex I activity without affecting complexes II–IV, reducing mitochondrial respiration, ATP-linked oxygen consumption and cellular ATP, with downstream attenuation of AKT/GSK-3β/β-catenin signaling (PMID:30123074). Its abundance in mitochondria is controlled by C9orf72, which recruits the prohibitin complex to block m-AAA protease-dependent degradation of TIMMDC1 and thereby preserve complex I function (PMID:33545050). A deep intronic variant (c.597-1340A>G) creates a cryptic splice site that abolishes TIMMDC1 function and causes a complex I-deficient mitochondriopathy, and splice-switching antisense oligonucleotides correcting this variant restore normal mRNA, protein and complex I function in patient fibroblasts (PMID:28604674, PMID:35091571).

1. 2000 Low

   Before any functional role was known, the gene needed basic molecular definition; this established TIMMDC1 (C3orf1) as a ubiquitously expressed, muscle-enriched four-pass membrane protein.

   Evidence cDNA cloning, Northern blot, and computational topology prediction

   PMID:11092749

   Open questions at the time

   • No functional or organellar assignment
   • Transmembrane topology only predicted, not experimentally resolved
   • No interaction or pathway data
2. 2013 High

   The central question of what process TIMMDC1 serves was answered by placing it as an inner-membrane complex I assembly factor physically tied to the MCIA machinery and required for complex I activity.

   Evidence Reciprocal Co-IP/AP-MS, fractionation, siRNA knockdown with complex I and respiration assays, and quantitative proteomics; independent native-gel/MS identification of TIMMDC1 in membrane-arm subcomplexes

   PMID:24191001 PMID:24344204

   Open questions at the time

   • Order of action within the MCIA pathway not defined
   • Direct substrate/subunit handoff not resolved
   • No structural model of TIMMDC1 in assembly intermediates
3. 2016 Medium

   Whether TIMMDC1 is a stable MCIA subunit rather than a peripheral interactor was tested, confirming its membership in the MCIA complex with ACAD9, ECSIT, NDUFAF1 and TMEM126B.

   Evidence Complexome profiling of TMEM126B-deficient patient cells

   PMID:27374774

   Open questions at the time

   • Stoichiometry within MCIA not defined
   • Single patient-cell context
   • Does not establish direct binary contacts
4. 2017 Medium

   It was unknown whether TIMMDC1 loss-of-function causes human disease; a deep intronic cryptic-splice variant established TIMMDC1 as a mitochondriopathy gene.

   Evidence RNA sequencing of patient fibroblasts revealing aberrant splicing

   PMID:28604674

   Open questions at the time

   • Single index finding of the variant
   • Genotype–phenotype spectrum not delineated
   • Mechanistic link to complex I deficiency inferred from splicing, not yet rescued
5. 2018 Medium

   The specificity and signaling consequences of TIMMDC1 loss were clarified, showing a complex I-selective defect that propagates to AKT/GSK-3β/β-catenin/c-Myc signaling and tumor cell behavior.

   Evidence shRNA knockdown in gastric cancer cells, complex I–IV activity assays, Seahorse flux, ATP quantification, pathway western blots, and xenografts

   PMID:30123074

   Open questions at the time

   • Whether signaling changes are direct or secondary to bioenergetic stress unresolved
   • Single cancer context
   • No demonstration that AKT pathway requires complex I per se
6. 2019 Medium

   The functional importance of the TIMMDC1 C-terminus was tested, showing a p.Arg225* truncation is hypomorphic and the C-terminus is dispensable for core assembly function.

   Evidence Complementation of TIMMDC1 knockout cells with the truncation mutant and complex I assembly assays

   PMID:30981218

   Open questions at the time

   • Domain mapping of the essential region incomplete
   • Quantitative degree of hypomorphism not detailed
   • No structural basis for partial activity
7. 2021 High

   How TIMMDC1 levels are maintained was addressed, defining a C9orf72/prohibitin axis that protects TIMMDC1 from m-AAA protease degradation to sustain complex I.

   Evidence Co-IP, C9orf72 knockout mouse and patient-derived neurons, proteomics, and complex I activity assays

   PMID:33545050

   Open questions at the time

   • Signals triggering m-AAA targeting of TIMMDC1 unknown
   • Direct protease cleavage site not mapped
   • Generalizability beyond neurons not tested
8. 2021 Medium

   The position of TIMMDC1 relative to other assembly factors was refined, placing it downstream of or alongside NDUFAF3/NDUFAF4 in Q-, N- and PP-b-module biogenesis.

   Evidence Genetic disruption in Drosophila with complexome profiling and double-mutant epistasis

   PMID:34386730

   Open questions at the time

   • Orthologous (Drosophila) system; human ordering not directly confirmed
   • Molecular nature of cooperation with NDUFAF3/4 unknown
   • Intermediate handoff steps undefined
9. 2022 High

   Whether the pathogenic splice defect is correctable was demonstrated, with splice-switching antisense oligonucleotides restoring TIMMDC1 mRNA, protein and complex I function in patient cells.

   Evidence Antisense oligonucleotide treatment of patient fibroblasts, RNA/protein analysis, quantitative proteomics, and Seahorse metabolic analysis

   PMID:35091571

   Open questions at the time

   • Efficacy shown in fibroblasts only, not in vivo
   • Durability and delivery not addressed
   • No clinical correlation
10. 2025 Low

    A post-transcriptional control layer was identified, with METTL3-mediated m6A methylation of TIMMDC1 mRNA suppressing its expression.

    Evidence Me-RIP and RIP assays, m6A site prediction, qRT-PCR, western blot, and EdU proliferation assay

    PMID:40409178

    Open questions at the time

    • Single lab with limited mechanistic depth from abstract
    • m6A reader and decay/translation mechanism not defined
    • Physiological context of regulation unclear

• The structural basis of how TIMMDC1 templates membrane-arm assembly and the precise sequence of subunit handoffs within the MCIA pathway remain unresolved.
• No structure of TIMMDC1 within an assembly intermediate
• Direct binary contacts with specific complex I subunits not mapped
• Timing of TIMMDC1 release during maturation unknown